Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A13412 | 29990865 | Biomed Pharmacother | Tangganjian decoction ameliorates type 2 diabetes mellitus and nonalcoholic fatty liver disease in rats by activating the IRS/PI3K/AKT signaling pathway. | 2018 | Details |
| A13413 | 29990551 | Biochim Biophys Acta Mol Basis Dis | Animal models of NAFLD from a hepatologist's point of view. | 2018 | Details |
| A13414 | 29990488 | Gastroenterology | Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis. | 2018 | Details |
| A13415 | 29989851 | Am J Physiol Endocrinol Metab | Saturated fatty acid combined with lipopolysaccharide stimulates a strong inflammatory response in hepatocytes in vivo and in vitro. | 2018 | Details |
| A13416 | 29989845 | Metab Syndr Relat Disord | Association Between Serum CK-18 Levels and the Degree of Liver Damage in Fructose-Induced Metabolic Syndrome. | 2018 | Details |
| A13417 | 29989347 | J Dig Dis | Serum levels of immunoglobulins in an adult population and their relationship with nonalcoholic fatty liver disease. | 2018 | Details |
| A13418 | 29989032 | Integr Med Res | A juvenile case with nonalcoholic steatohepatitis and traditional Korean medicine-based treatment. | 2018 | Details |
| A13419 | 29988867 | World J Transplant | Perioperative glucose management and outcomes in liver transplant recipients: A qualitative systematic review. | 2018 | Details |
| A13420 | 29987933 | J Agric Food Chem | Pectin Alleviates High Fat (Lard) Diet-Induced Nonalcoholic Fatty Liver Disease in Mice: Possible Role of Short-Chain Fatty Acids and Gut Microbiota Regulated by Pectin. | 2018 | Details |
| A13421 | 29986142 | J Med Chem | Monoacylglycerol Acyltransferase 2 (MGAT2) Inhibitors for the Treatment of Metabolic Diseases and Nonalcoholic Steatohepatitis (NASH). | 2018 | Details |
| A13422 | 29985186 | Transplantation | Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis. | 2019 | Details |
| A13423 | 29984415 | Aliment Pharmacol Ther | Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors. | 2018 | Details |
| A13424 | 29984351 | J Patient Rep Outcomes | Health-related quality of life burden of nonalcoholic steatohepatitis: a robust pragmatic literature review. | 2018 | Details |
| A13425 | 29983793 | Open Access Maced J Med Sci | Serum Markers of Iron Metabolism in Chronic Liver Diseases. | 2018 | Details |
| A13426 | 29983642 | Proteome Sci | Correction to: Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease. | 2018 | Details |
| A13428 | 29981428 | J Hepatol | Urea cycle dysregulation in non-alcoholic fatty liver disease. | 2018 | Details |
| A13429 | 29980170 | BMC Gastroenterol | Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal. | 2018 | Details |
| A13430 | 29978151 | J Endocr Soc | Unveiling "Musica Universalis" of the Cell: A Brief History of Biological 12-Hour Rhythms. | 2018 | Details |
| A13431 | 29976400 | J Food Drug Anal | Tetrahydrocurcumin ameliorates free fatty acid-induced hepatic steatosis and improves insulin resistance in HepG2 cells. | 2018 | Details |
| A13432 | 29976192 | BMC Pediatr | Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010-2015. | 2018 | Details |
| A13433 | 29975946 | Cell Physiol Biochem | Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model. | 2018 | Details |
| A13434 | 29975579 | Endocr Pract | Nonalcoholic Fatty Liver Disease and Risk of Diabetes: A Prospective Study in China. | 2018 | Details |
| A13435 | 29974828 | Curr Mol Med | The LEPR K109R and Q223R Might Contribute to the Risk of NAFLD: A Meta-Analysis. | 2018 | Details |
| A13436 | 29974624 | Hepatol Res | Accuracy of non-invasive scoring systems for diagnosing non-alcoholic steatohepatitis-related fibrosis: Multicenter validation study. | 2018 | Details |
| A13437 | 29974410 | Hepatol Int | Non-alcoholic hepatic steatosis attenuates hepatitis B virus replication in an HBV-immunocompetent mouse model. | 2018 | Details |
| A13438 | 29973915 | Front Endocrinol (Lausanne) | Nonalcoholic Fatty Liver Disease in University Rugby Football Players. | 2018 | Details |
| A13439 | 29973714 | Nature | Author Correction: Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. | 2018 | Details |
| A13440 | 29973631 | Sci Rep | Association of Lipoprotein-Associated Phospholipase A2 with the Prevalence of Nonalcoholic Fatty Liver Disease: A Result from the APAC Study. | 2018 | Details |
| A13441 | 29972240 | J Physiol | Maternal obesity has sex-dependent effects on insulin, glucose and lipid metabolism and the liver transcriptome in young adult rat offspring. | 2018 | Details |
| A13442 | 29971772 | J Pathol | Geranylgeranyl diphosphate synthase (GGPPS) regulates non-alcoholic fatty liver disease (NAFLD)-fibrosis progression by determining hepatic glucose/fatty acid preference under high-fat diet conditions. | 2018 | Details |
| A13443 | 29971527 | Diabetologia | Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study. | 2018 | Details |
| A13444 | 29970888 | Nat Rev Gastroenterol Hepatol | Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions. | 2018 | Details |
| A13445 | 29970566 | Anticancer Res | Global Liver Gene Expression Analysis on a Murine Hepatic Steatosis Model Treated with Mulberry (Morus alba L.) Leaf Powder. | 2018 | Details |
| A13446 | 29970524 | Anticancer Res | Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase Activity in the Serum of Patients with Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A13447 | 29969922 | Expert Opin Drug Metab Toxicol | Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugs. | 2018 | Details |
| A13448 | 29969718 | Free Radic Biol Med | IRE1α aggravates ischemia reperfusion injury of fatty liver by regulating phenotypic transformation of kupffer cells. | 2018 | Details |
| A13449 | 29968484 | J Int Med Res | Chronic heart failure in patients with nonalcoholic fatty liver disease: prevalence, clinical features, and relevance. | 2018 | Details |
| A13450 | 29967579 | Front Aging Neurosci | Integrated Analysis and Identification of Novel Biomarkers in Parkinson's Disease. | 2018 | Details |
| A13451 | 29967350 | Nat Med | Mechanisms of NAFLD development and therapeutic strategies. | 2018 | Details |
| A13452 | 29965973 | PLoS One | Long-term metabolic effects of malnutrition: Liver steatosis and insulin resistance following early-life protein restriction. | 2018 | Details |
| A13453 | 29964161 | Pharmacol Res | Human-based systems: Mechanistic NASH modelling just around the corner? | 2018 | Details |
| A13454 | 29964102 | Int J Biol Macromol | Chicory (Cichorium intybus L.) polysaccharides attenuate high-fat diet induced non-alcoholic fatty liver disease via AMPK activation. | 2018 | Details |
| A13455 | 29963902 | Antioxid Redox Signal | A Cross Talk Between BRG1 and Males Absent on the First Contributes to Reactive Oxygen Species Production in a Mouse Model of Nonalcoholic Steatohepatitis. | 2018 | Details |
| A13456 | 29963470 | Euroasian J Hepatogastroenterol | Changing Etiology in Liver Cirrhosis in Sapporo, Japan. | 2018 | Details |
| A13457 | 29963467 | Euroasian J Hepatogastroenterol | Nonalcoholic Fatty Liver Disease: Identifying the Disease Burden in Sri Lanka. | 2018 | Details |
| A13458 | 29963463 | Euroasian J Hepatogastroenterol | Hepatocellular Carcinoma in Malaysia and Its Changing Trend. | 2018 | Details |
| A13459 | 29963461 | Euroasian J Hepatogastroenterol | Nonalcoholic Fatty Liver Disease: Time to Take the Bull by the Horns. | 2018 | Details |
| A13460 | 29962430 | J Nutr Sci Vitaminol (Tokyo) | L-Lysine Attenuates Hepatic Steatosis in Senescence-Accelerated Mouse Prone 8 Mice. | 2018 | Details |
| A13461 | 29961332 | J Agric Food Chem | Sodium Butyrate Ameliorates High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease through Peroxisome Proliferator-Activated Receptor α-Mediated Activation of β Oxidation and Suppression of Inflammation. | 2018 | Details |
| A13462 | 29960159 | Nutrition | Caffeic acid ameliorates hepatic steatosis and reduces ER stress in high fat diet-induced obese mice by regulating autophagy. | 2018 | Details |
| A13463 | 29959534 | Med Mol Morphol | Combination of APD668, a G protein-coupled receptor 119 agonist with linagliptin, a DPPIV inhibitor, prevents progression of steatohepatitis in a murine model of non-alcoholic steatohepatitis with diabetes. | 2018 | Details |
| A13464 | 29959418 | Lab Invest | Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking water. | 2018 | Details |
| A13465 | 29959134 | Drug Metab Dispos | Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation. | 2018 | Details |
| A13466 | 29958960 | J Ethnopharmacol | The polyherbal drug GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits hepatic steatosis and fibroinflammtion in high-fat diet-induced obese mice. | 2018 | Details |
| A13467 | 29957886 | J Diabetes Investig | Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: A randomized trial. | 2018 | Details |
| A13468 | 29956790 | Mol Med Rep | Effects of isomaltulose on insulin resistance and metabolites in patients with non‑alcoholic fatty liver disease: A metabolomic analysis. | 2018 | Details |
| A13469 | 29956688 | Saudi J Gastroenterol | Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030. | 2018 | Details |
| A13470 | 29956213 | Adv Exp Med Biol | Current Prevention and Treatment Options for NAFLD. | 2018 | Details |
| A13471 | 29956212 | Adv Exp Med Biol | Animal Models of Non-alcoholic Fatty Liver Diseases and Its Associated Liver Cancer. | 2018 | Details |
| A13472 | 29956211 | Adv Exp Med Biol | Autophagy, NAFLD and NAFLD-Related HCC. | 2018 | Details |
| A13473 | 29956210 | Adv Exp Med Biol | Microbiota, Obesity and NAFLD. | 2018 | Details |
| A13474 | 29956209 | Adv Exp Med Biol | The Influence of Gut Microbial Metabolism on the Development and Progression of Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A13475 | 29956208 | Adv Exp Med Biol | Dysregulated Epigenetic Modifications in the Pathogenesis of NAFLD-HCC. | 2018 | Details |
| A13476 | 29956207 | Adv Exp Med Biol | Hepatocellular Carcinoma in Obesity: Finding a Needle in the Haystack? | 2018 | Details |
| A13477 | 29956206 | Adv Exp Med Biol | NAFLD Related-HCC: The Relationship with Metabolic Disorders. | 2018 | Details |
| A13478 | 29956205 | Adv Exp Med Biol | Chemokines and Chemokine Receptors in the Development of NAFLD. | 2018 | Details |
| A13479 | 29956204 | Adv Exp Med Biol | Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease. | 2018 | Details |
| A13480 | 29956203 | Adv Exp Med Biol | Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC. | 2018 | Details |
| A13481 | 29956202 | Adv Exp Med Biol | Introduction. | 2018 | Details |
| A13482 | 29956192 | Adv Exp Med Biol | Developmental Origins of Nonalcoholic Fatty Liver Disease (NAFLD). | 2018 | Details |
| A13483 | 29955245 | Oxid Med Cell Longev | Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression. | 2018 | Details |
| A13485 | 29954288 | J Bioinform Comput Biol | Succinate aggravates NAFLD progression to liver cancer on the onset of obesity: An in silico model. | 2018 | Details |
| A13486 | 29954129 | Int J Mol Sci | Insights into the Role of PPARβ/δ in NAFLD. | 2018 | Details |
| A13487 | 29953740 | Basic Clin Pharmacol Toxicol | Liraglutide Decreases Hepatic Inflammation and Injury in Advanced Lean Non-Alcoholic Steatohepatitis. | 2018 | Details |
| A13488 | 29953011 | Medicine (Baltimore) | Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China. | 2018 | Details |
| A13489 | 29951900 | Abdom Radiol (NY) | Reader agreement and accuracy of ultrasound features for hepatic steatosis. | 2019 | Details |
| A13490 | 29951838 | Biochem Genet | Critical Roles of microRNAs in the Pathogenesis of Fatty Liver: New Advances, Challenges, and Potential Directions. | 2018 | Details |
| A13491 | 29951367 | J Clin Transl Hepatol | Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13492 | 29951362 | J Clin Transl Hepatol | Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies. | 2018 | Details |
| A13493 | 29950116 | Expert Opin Investig Drugs | MSDC-0602K, a metabolic modulator directed at the core pathology of non-alcoholic steatohepatitis. | 2018 | Details |
| A13494 | 29949199 | J Gastroenterol Hepatol | Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients. | 2018 | Details |
| A13495 | 29948900 | Sci China Life Sci | Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients. | 2018 | Details |
| A13496 | 29948305 | J Gastroenterol | Increase in the skeletal muscle mass to body fat mass ratio predicts the decline in transaminase in patients with nonalcoholic fatty liver disease. | 2018 | Details |
| A13497 | 29947894 | Arch Toxicol | Integrated transcriptomics and metabolomics reveal signatures of lipid metabolism dysregulation in HepaRG liver cells exposed to PCB 126. | 2018 | Details |
| A13498 | 29947322 | Br J Nutr | Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial. | 2018 | Details |
| A13499 | 29947156 | Phytother Res | Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: A systematic review and meta-analysis of clinical trials. | 2018 | Details |
| A13500 | 29947103 | Eur J Clin Invest | Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver disease. | 2018 | Details |
| A13501 | 29947044 | Clin Endocrinol (Oxf) | High Irisin levels in nondiabetic HIV-infected males are associated with insulin resistance, nonalcoholic fatty liver disease, and subclinical atherosclerosis. | 2018 | Details |
| A13502 | 29946793 | Amino Acids | Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro. | 2018 | Details |
| A13503 | 29946426 | F1000Res | Recent advances in understanding and managing non-alcoholic fatty liver disease. | 2018 | Details |
| A13504 | 29945982 | J Endocrinol | INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function. | 2018 | Details |
| A13505 | 29944670 | PLoS One | Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH. | 2018 | Details |
| A13506 | 29943733 | J Breath Res | The characterisation of hepatic mitochondrial function in patients with non-alcoholic fatty liver disease (NAFLD) using the 13C-ketoisocaproate breath test. | 2018 | Details |
| A13508 | 29942422 | J Clin Aesthet Dermatol | A Case-control Study to Evaluate the Prevalence of Nonalcoholic Fatty Liver Disease Among Patients with Moderate-to-severe Psoriasis. | 2018 | Details |
| A13509 | 29942096 | Nat Med | Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. | 2018 | Details |
| A13510 | 29941024 | Trials | Effects of an exercise program on hepatic metabolism, hepatic fat, and cardiovascular health in overweight/obese adolescents from Bogotá, Colombia (the HEPAFIT study): study protocol for a randomized controlled trial. | 2018 | Details |
| A13512 | 29940269 | J Hepatol | Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. | 2018 | Details |
| A13514 | 29936743 | Zhonghua Liu Xing Bing Xue Za Zhi | [Association between fatty liver and type 2 diabetes in the baseline population of Jinchang Cohort]. | 2018 | Details |
| A13515 | 29936596 | Cell Mol Life Sci | Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. | 2018 | Details |
| A13516 | 29936297 | Toxicol Lett | Isoniazid-induced hepatotoxicity and neurotoxicity in rats investigated by 1H NMR based metabolomics approach. | 2018 | Details |